nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—Glucose-6-phosphate dehydrogenase deficiency—Glimepiride—type 2 diabetes mellitus	0.0399	0.0792	CcSEcCtD
Phenazopyridine—SCN11A—peripheral nervous system—type 2 diabetes mellitus	0.0232	0.165	CbGeAlD
Phenazopyridine—SCN11A—nerve—type 2 diabetes mellitus	0.0181	0.129	CbGeAlD
Phenazopyridine—SCN8A—peripheral nervous system—type 2 diabetes mellitus	0.0176	0.125	CbGeAlD
Phenazopyridine—SCN8A—nerve—type 2 diabetes mellitus	0.0137	0.0977	CbGeAlD
Phenazopyridine—Digestion impaired—Tolbutamide—type 2 diabetes mellitus	0.0133	0.0264	CcSEcCtD
Phenazopyridine—Digestion impaired—Tolazamide—type 2 diabetes mellitus	0.0121	0.024	CcSEcCtD
Phenazopyridine—Digestion impaired—Chlorpropamide—type 2 diabetes mellitus	0.0121	0.024	CcSEcCtD
Phenazopyridine—SCN10A—peripheral nervous system—type 2 diabetes mellitus	0.0118	0.0838	CbGeAlD
Phenazopyridine—SCN10A—nerve—type 2 diabetes mellitus	0.00916	0.0654	CbGeAlD
Phenazopyridine—Digestion impaired—Glipizide—type 2 diabetes mellitus	0.00803	0.0159	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Tolbutamide—type 2 diabetes mellitus	0.00715	0.0142	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Tolazamide—type 2 diabetes mellitus	0.0065	0.0129	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Chlorpropamide—type 2 diabetes mellitus	0.0065	0.0129	CcSEcCtD
Phenazopyridine—Nephrolithiasis—Sitagliptin—type 2 diabetes mellitus	0.00621	0.0123	CcSEcCtD
Phenazopyridine—Digestion impaired—Glyburide—type 2 diabetes mellitus	0.00618	0.0123	CcSEcCtD
Phenazopyridine—Calculus of kidney—Gliclazide—type 2 diabetes mellitus	0.00566	0.0112	CcSEcCtD
Phenazopyridine—Digestion impaired—Gliclazide—type 2 diabetes mellitus	0.00555	0.011	CcSEcCtD
Phenazopyridine—SCN7A—cardiovascular system—type 2 diabetes mellitus	0.00538	0.0384	CbGeAlD
Phenazopyridine—Haemolytic anaemia—Repaglinide—type 2 diabetes mellitus	0.00521	0.0103	CcSEcCtD
Phenazopyridine—Visual disturbance—Repaglinide—type 2 diabetes mellitus	0.00497	0.00986	CcSEcCtD
Phenazopyridine—SCN7A—adipose tissue—type 2 diabetes mellitus	0.00475	0.0339	CbGeAlD
Phenazopyridine—SCN9A—nephron tubule—type 2 diabetes mellitus	0.00469	0.0335	CbGeAlD
Phenazopyridine—Nephrolithiasis—Gliclazide—type 2 diabetes mellitus	0.00461	0.00915	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Glipizide—type 2 diabetes mellitus	0.00431	0.00856	CcSEcCtD
Phenazopyridine—Jaundice—Acarbose—type 2 diabetes mellitus	0.00424	0.00841	CcSEcCtD
Phenazopyridine—Visual disturbance—Glipizide—type 2 diabetes mellitus	0.00411	0.00816	CcSEcCtD
Phenazopyridine—Jaundice—Nateglinide—type 2 diabetes mellitus	0.00409	0.00811	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Glimepiride—type 2 diabetes mellitus	0.00403	0.00799	CcSEcCtD
Phenazopyridine—Visual disturbance—Pioglitazone—type 2 diabetes mellitus	0.00394	0.00781	CcSEcCtD
Phenazopyridine—Hepatitis—Acarbose—type 2 diabetes mellitus	0.0039	0.00774	CcSEcCtD
Phenazopyridine—SCN9A—adipose tissue—type 2 diabetes mellitus	0.00372	0.0265	CbGeAlD
Phenazopyridine—SCN4A—kidney—type 2 diabetes mellitus	0.00368	0.0263	CbGeAlD
Phenazopyridine—SCN10A—nephron tubule—type 2 diabetes mellitus	0.00357	0.0255	CbGeAlD
Phenazopyridine—Jaundice—Repaglinide—type 2 diabetes mellitus	0.00354	0.00702	CcSEcCtD
Phenazopyridine—Digestion impaired—Ramipril—type 2 diabetes mellitus	0.00353	0.00701	CcSEcCtD
Phenazopyridine—Visual disturbance—Bromocriptine—type 2 diabetes mellitus	0.00346	0.00687	CcSEcCtD
Phenazopyridine—SCN7A—liver—type 2 diabetes mellitus	0.00333	0.0237	CbGeAlD
Phenazopyridine—Haemolytic anaemia—Glyburide—type 2 diabetes mellitus	0.00332	0.00659	CcSEcCtD
Phenazopyridine—SCN4A—adipose tissue—type 2 diabetes mellitus	0.00332	0.0237	CbGeAlD
Phenazopyridine—Hepatitis—Repaglinide—type 2 diabetes mellitus	0.00326	0.00646	CcSEcCtD
Phenazopyridine—SCN2A—cortex of kidney—type 2 diabetes mellitus	0.00317	0.0226	CbGeAlD
Phenazopyridine—Visual disturbance—Glyburide—type 2 diabetes mellitus	0.00316	0.00628	CcSEcCtD
Phenazopyridine—Visual impairment—Repaglinide—type 2 diabetes mellitus	0.00314	0.00623	CcSEcCtD
Phenazopyridine—Hepatitis—Rosiglitazone—type 2 diabetes mellitus	0.00308	0.00611	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Miglitol—type 2 diabetes mellitus	0.00305	0.00604	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Gliclazide—type 2 diabetes mellitus	0.00298	0.00592	CcSEcCtD
Phenazopyridine—Jaundice—Glipizide—type 2 diabetes mellitus	0.00293	0.00581	CcSEcCtD
Phenazopyridine—SCN5A—cardiovascular system—type 2 diabetes mellitus	0.00292	0.0208	CbGeAlD
Phenazopyridine—SCN3A—kidney—type 2 diabetes mellitus	0.00286	0.0204	CbGeAlD
Phenazopyridine—Visual disturbance—Gliclazide—type 2 diabetes mellitus	0.00284	0.00564	CcSEcCtD
Phenazopyridine—Dyspepsia—Tolbutamide—type 2 diabetes mellitus	0.00279	0.00554	CcSEcCtD
Phenazopyridine—SCN3A—cortex of kidney—type 2 diabetes mellitus	0.00279	0.0199	CbGeAlD
Phenazopyridine—Gastrointestinal disorder—Tolbutamide—type 2 diabetes mellitus	0.00274	0.00543	CcSEcCtD
Phenazopyridine—Jaundice—Glimepiride—type 2 diabetes mellitus	0.00273	0.00542	CcSEcCtD
Phenazopyridine—Hepatitis—Glipizide—type 2 diabetes mellitus	0.00269	0.00535	CcSEcCtD
Phenazopyridine—Visual impairment—Glipizide—type 2 diabetes mellitus	0.0026	0.00515	CcSEcCtD
Phenazopyridine—Hepatitis—Pioglitazone—type 2 diabetes mellitus	0.00258	0.00512	CcSEcCtD
Phenazopyridine—SCN3A—adipose tissue—type 2 diabetes mellitus	0.00258	0.0184	CbGeAlD
Phenazopyridine—Dyspepsia—Chlorpropamide—type 2 diabetes mellitus	0.00254	0.00504	CcSEcCtD
Phenazopyridine—Dyspepsia—Tolazamide—type 2 diabetes mellitus	0.00254	0.00504	CcSEcCtD
Phenazopyridine—Hepatitis—Glimepiride—type 2 diabetes mellitus	0.00251	0.00499	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Tolazamide—type 2 diabetes mellitus	0.00249	0.00494	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Chlorpropamide—type 2 diabetes mellitus	0.00249	0.00494	CcSEcCtD
Phenazopyridine—Visual impairment—Pioglitazone—type 2 diabetes mellitus	0.00249	0.00494	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Linagliptin—type 2 diabetes mellitus	0.00247	0.00489	CcSEcCtD
Phenazopyridine—Dyspepsia—Acarbose—type 2 diabetes mellitus	0.00244	0.00484	CcSEcCtD
Phenazopyridine—Visual impairment—Glimepiride—type 2 diabetes mellitus	0.00242	0.00481	CcSEcCtD
Phenazopyridine—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.00241	0.00479	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Acarbose—type 2 diabetes mellitus	0.00239	0.00475	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Irbesartan—type 2 diabetes mellitus	0.00235	0.00467	CcSEcCtD
Phenazopyridine—Dyspepsia—Nateglinide—type 2 diabetes mellitus	0.00235	0.00467	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Nateglinide—type 2 diabetes mellitus	0.00231	0.00458	CcSEcCtD
Phenazopyridine—Jaundice—Glyburide—type 2 diabetes mellitus	0.00225	0.00447	CcSEcCtD
Phenazopyridine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00224	0.00445	CcSEcCtD
Phenazopyridine—Visual disturbance—Irbesartan—type 2 diabetes mellitus	0.00224	0.00445	CcSEcCtD
Phenazopyridine—Rash—Miglitol—type 2 diabetes mellitus	0.00222	0.00441	CcSEcCtD
Phenazopyridine—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00222	0.00441	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Losartan—type 2 diabetes mellitus	0.00222	0.0044	CcSEcCtD
Phenazopyridine—Visual impairment—Bromocriptine—type 2 diabetes mellitus	0.00219	0.00434	CcSEcCtD
Phenazopyridine—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.0021	0.00417	CcSEcCtD
Phenazopyridine—Nausea—Miglitol—type 2 diabetes mellitus	0.0021	0.00416	CcSEcCtD
Phenazopyridine—Hepatitis—Glyburide—type 2 diabetes mellitus	0.00207	0.00411	CcSEcCtD
Phenazopyridine—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00204	0.00405	CcSEcCtD
Phenazopyridine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.00204	0.00405	CcSEcCtD
Phenazopyridine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.00204	0.00405	CcSEcCtD
Phenazopyridine—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.00204	0.00404	CcSEcCtD
Phenazopyridine—Jaundice—Gliclazide—type 2 diabetes mellitus	0.00202	0.00401	CcSEcCtD
Phenazopyridine—Rash—Tolbutamide—type 2 diabetes mellitus	0.002	0.00397	CcSEcCtD
Phenazopyridine—Visual impairment—Glyburide—type 2 diabetes mellitus	0.002	0.00397	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Repaglinide—type 2 diabetes mellitus	0.002	0.00396	CcSEcCtD
Phenazopyridine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00199	0.00394	CcSEcCtD
Phenazopyridine—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00197	0.00392	CcSEcCtD
Phenazopyridine—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00197	0.00391	CcSEcCtD
Phenazopyridine—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00195	0.00388	CcSEcCtD
Phenazopyridine—Haemolytic anaemia—Ramipril—type 2 diabetes mellitus	0.0019	0.00377	CcSEcCtD
Phenazopyridine—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.0019	0.00376	CcSEcCtD
Phenazopyridine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.00189	0.00375	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Rosiglitazone—type 2 diabetes mellitus	0.00189	0.00375	CcSEcCtD
Phenazopyridine—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00188	0.00374	CcSEcCtD
Phenazopyridine—Hepatitis—Gliclazide—type 2 diabetes mellitus	0.00186	0.00369	CcSEcCtD
Phenazopyridine—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00183	0.00364	CcSEcCtD
Phenazopyridine—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00183	0.00363	CcSEcCtD
Phenazopyridine—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00182	0.00361	CcSEcCtD
Phenazopyridine—Rash—Tolazamide—type 2 diabetes mellitus	0.00182	0.00361	CcSEcCtD
Phenazopyridine—Headache—Tolazamide—type 2 diabetes mellitus	0.00181	0.00359	CcSEcCtD
Phenazopyridine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00181	0.00359	CcSEcCtD
Phenazopyridine—Rash—Linagliptin—type 2 diabetes mellitus	0.0018	0.00357	CcSEcCtD
Phenazopyridine—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.0018	0.00357	CcSEcCtD
Phenazopyridine—Visual impairment—Gliclazide—type 2 diabetes mellitus	0.00179	0.00356	CcSEcCtD
Phenazopyridine—Headache—Linagliptin—type 2 diabetes mellitus	0.00179	0.00355	CcSEcCtD
Phenazopyridine—Vomiting—Acarbose—type 2 diabetes mellitus	0.00176	0.0035	CcSEcCtD
Phenazopyridine—Rash—Acarbose—type 2 diabetes mellitus	0.00175	0.00347	CcSEcCtD
Phenazopyridine—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00175	0.00347	CcSEcCtD
Phenazopyridine—Nausea—Tolazamide—type 2 diabetes mellitus	0.00171	0.0034	CcSEcCtD
Phenazopyridine—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00171	0.0034	CcSEcCtD
Phenazopyridine—Hepatitis—Valsartan—type 2 diabetes mellitus	0.00171	0.00339	CcSEcCtD
Phenazopyridine—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.0017	0.00338	CcSEcCtD
Phenazopyridine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.0017	0.00337	CcSEcCtD
Phenazopyridine—Hepatitis—Orlistat—type 2 diabetes mellitus	0.00169	0.00335	CcSEcCtD
Phenazopyridine—Rash—Nateglinide—type 2 diabetes mellitus	0.00169	0.00334	CcSEcCtD
Phenazopyridine—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.00169	0.00334	CcSEcCtD
Phenazopyridine—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00168	0.00334	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.00165	0.00328	CcSEcCtD
Phenazopyridine—Nausea—Acarbose—type 2 diabetes mellitus	0.00165	0.00327	CcSEcCtD
Phenazopyridine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00164	0.00325	CcSEcCtD
Phenazopyridine—Jaundice—Irbesartan—type 2 diabetes mellitus	0.0016	0.00317	CcSEcCtD
Phenazopyridine—Nausea—Nateglinide—type 2 diabetes mellitus	0.00159	0.00315	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.00158	0.00314	CcSEcCtD
Phenazopyridine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00158	0.00314	CcSEcCtD
Phenazopyridine—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.00157	0.00312	CcSEcCtD
Phenazopyridine—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.00157	0.00311	CcSEcCtD
Phenazopyridine—Hepatitis—Metformin—type 2 diabetes mellitus	0.00156	0.00309	CcSEcCtD
Phenazopyridine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00155	0.00307	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00154	0.00306	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00154	0.00305	CcSEcCtD
Phenazopyridine—Jaundice—Losartan—type 2 diabetes mellitus	0.0015	0.00298	CcSEcCtD
Phenazopyridine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.0015	0.00297	CcSEcCtD
Phenazopyridine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00147	0.00292	CcSEcCtD
Phenazopyridine—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.00147	0.00292	CcSEcCtD
Phenazopyridine—Rash—Repaglinide—type 2 diabetes mellitus	0.00146	0.00289	CcSEcCtD
Phenazopyridine—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00146	0.00289	CcSEcCtD
Phenazopyridine—Headache—Repaglinide—type 2 diabetes mellitus	0.00145	0.00288	CcSEcCtD
Phenazopyridine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00281	CcSEcCtD
Phenazopyridine—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.00142	0.00281	CcSEcCtD
Phenazopyridine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00141	0.0028	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00139	0.00276	CcSEcCtD
Phenazopyridine—Hepatitis—Losartan—type 2 diabetes mellitus	0.00138	0.00275	CcSEcCtD
Phenazopyridine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00138	0.00274	CcSEcCtD
Phenazopyridine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00138	0.00273	CcSEcCtD
Phenazopyridine—Nausea—Repaglinide—type 2 diabetes mellitus	0.00137	0.00273	CcSEcCtD
Phenazopyridine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00137	0.00272	CcSEcCtD
Phenazopyridine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00135	0.00269	CcSEcCtD
Phenazopyridine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00135	0.00268	CcSEcCtD
Phenazopyridine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00132	0.00261	CcSEcCtD
Phenazopyridine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00131	0.0026	CcSEcCtD
Phenazopyridine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00131	0.0026	CcSEcCtD
Phenazopyridine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.0013	0.00258	CcSEcCtD
Phenazopyridine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.0013	0.00257	CcSEcCtD
Phenazopyridine—Jaundice—Ramipril—type 2 diabetes mellitus	0.00129	0.00256	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00127	0.00252	CcSEcCtD
Phenazopyridine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00126	0.00251	CcSEcCtD
Phenazopyridine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00125	0.00249	CcSEcCtD
Phenazopyridine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00122	0.00243	CcSEcCtD
Phenazopyridine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00122	0.00242	CcSEcCtD
Phenazopyridine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00122	0.00242	CcSEcCtD
Phenazopyridine—Rash—Glipizide—type 2 diabetes mellitus	0.00121	0.00239	CcSEcCtD
Phenazopyridine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00121	0.00239	CcSEcCtD
Phenazopyridine—Headache—Glipizide—type 2 diabetes mellitus	0.0012	0.00238	CcSEcCtD
Phenazopyridine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.00119	0.00235	CcSEcCtD
Phenazopyridine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00116	0.00231	CcSEcCtD
Phenazopyridine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00115	0.00228	CcSEcCtD
Phenazopyridine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.00114	0.00227	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00114	0.00227	CcSEcCtD
Phenazopyridine—Nausea—Glipizide—type 2 diabetes mellitus	0.00114	0.00226	CcSEcCtD
Phenazopyridine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00114	0.00225	CcSEcCtD
Phenazopyridine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00113	0.00225	CcSEcCtD
Phenazopyridine—Rash—Glimepiride—type 2 diabetes mellitus	0.00113	0.00223	CcSEcCtD
Phenazopyridine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00113	0.00223	CcSEcCtD
Phenazopyridine—Rash—Sitagliptin—type 2 diabetes mellitus	0.00112	0.00223	CcSEcCtD
Phenazopyridine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00112	0.00223	CcSEcCtD
Phenazopyridine—Headache—Glimepiride—type 2 diabetes mellitus	0.00112	0.00222	CcSEcCtD
Phenazopyridine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00112	0.00221	CcSEcCtD
Phenazopyridine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.0011	0.00219	CcSEcCtD
Phenazopyridine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00109	0.00215	CcSEcCtD
Phenazopyridine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00107	0.00212	CcSEcCtD
Phenazopyridine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00106	0.00211	CcSEcCtD
Phenazopyridine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00106	0.0021	CcSEcCtD
Phenazopyridine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00106	0.0021	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00105	0.00208	CcSEcCtD
Phenazopyridine—Pruritus—Glyburide—type 2 diabetes mellitus	0.00104	0.00207	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00104	0.00206	CcSEcCtD
Phenazopyridine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00203	CcSEcCtD
Phenazopyridine—Rash—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00202	CcSEcCtD
Phenazopyridine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00201	CcSEcCtD
Phenazopyridine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00101	0.002	CcSEcCtD
Phenazopyridine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00101	0.002	CcSEcCtD
Phenazopyridine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000975	0.00193	CcSEcCtD
Phenazopyridine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000974	0.00193	CcSEcCtD
Phenazopyridine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000957	0.0019	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000956	0.0019	CcSEcCtD
Phenazopyridine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000937	0.00186	CcSEcCtD
Phenazopyridine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000936	0.00186	CcSEcCtD
Phenazopyridine—Rash—Glyburide—type 2 diabetes mellitus	0.000929	0.00184	CcSEcCtD
Phenazopyridine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000928	0.00184	CcSEcCtD
Phenazopyridine—Headache—Glyburide—type 2 diabetes mellitus	0.000923	0.00183	CcSEcCtD
Phenazopyridine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000919	0.00182	CcSEcCtD
Phenazopyridine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000905	0.0018	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000902	0.00179	CcSEcCtD
Phenazopyridine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000896	0.00178	CcSEcCtD
Phenazopyridine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000885	0.00176	CcSEcCtD
Phenazopyridine—Nausea—Glyburide—type 2 diabetes mellitus	0.000875	0.00174	CcSEcCtD
Phenazopyridine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000865	0.00172	CcSEcCtD
Phenazopyridine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00086	0.00171	CcSEcCtD
Phenazopyridine—Pruritus—Orlistat—type 2 diabetes mellitus	0.00085	0.00169	CcSEcCtD
Phenazopyridine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000841	0.00167	CcSEcCtD
Phenazopyridine—Rash—Gliclazide—type 2 diabetes mellitus	0.000834	0.00166	CcSEcCtD
Phenazopyridine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000833	0.00165	CcSEcCtD
Phenazopyridine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000832	0.00165	CcSEcCtD
Phenazopyridine—Headache—Gliclazide—type 2 diabetes mellitus	0.000829	0.00164	CcSEcCtD
Phenazopyridine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000822	0.00163	CcSEcCtD
Phenazopyridine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000786	0.00156	CcSEcCtD
Phenazopyridine—Pruritus—Metformin—type 2 diabetes mellitus	0.000783	0.00155	CcSEcCtD
Phenazopyridine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000773	0.00153	CcSEcCtD
Phenazopyridine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00077	0.00153	CcSEcCtD
Phenazopyridine—Rash—Valsartan—type 2 diabetes mellitus	0.000766	0.00152	CcSEcCtD
Phenazopyridine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000766	0.00152	CcSEcCtD
Phenazopyridine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000764	0.00152	CcSEcCtD
Phenazopyridine—Headache—Valsartan—type 2 diabetes mellitus	0.000761	0.00151	CcSEcCtD
Phenazopyridine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000757	0.0015	CcSEcCtD
Phenazopyridine—Rash—Orlistat—type 2 diabetes mellitus	0.000757	0.0015	CcSEcCtD
Phenazopyridine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000757	0.0015	CcSEcCtD
Phenazopyridine—Headache—Orlistat—type 2 diabetes mellitus	0.000752	0.00149	CcSEcCtD
Phenazopyridine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000742	0.00147	CcSEcCtD
Phenazopyridine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000739	0.00147	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000728	0.00144	CcSEcCtD
Phenazopyridine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000724	0.00144	CcSEcCtD
Phenazopyridine—Nausea—Valsartan—type 2 diabetes mellitus	0.000722	0.00143	CcSEcCtD
Phenazopyridine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000715	0.00142	CcSEcCtD
Phenazopyridine—Nausea—Orlistat—type 2 diabetes mellitus	0.000713	0.00142	CcSEcCtD
Phenazopyridine—Vomiting—Metformin—type 2 diabetes mellitus	0.000704	0.0014	CcSEcCtD
Phenazopyridine—Rash—Metformin—type 2 diabetes mellitus	0.000698	0.00138	CcSEcCtD
Phenazopyridine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000697	0.00138	CcSEcCtD
Phenazopyridine—Pruritus—Losartan—type 2 diabetes mellitus	0.000695	0.00138	CcSEcCtD
Phenazopyridine—Headache—Metformin—type 2 diabetes mellitus	0.000693	0.00138	CcSEcCtD
Phenazopyridine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000673	0.00133	CcSEcCtD
Phenazopyridine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000664	0.00132	CcSEcCtD
Phenazopyridine—Rash—Irbesartan—type 2 diabetes mellitus	0.000659	0.00131	CcSEcCtD
Phenazopyridine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000658	0.00131	CcSEcCtD
Phenazopyridine—Nausea—Metformin—type 2 diabetes mellitus	0.000657	0.0013	CcSEcCtD
Phenazopyridine—Headache—Irbesartan—type 2 diabetes mellitus	0.000654	0.0013	CcSEcCtD
Phenazopyridine—Vomiting—Losartan—type 2 diabetes mellitus	0.000625	0.00124	CcSEcCtD
Phenazopyridine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000621	0.00123	CcSEcCtD
Phenazopyridine—Nausea—Irbesartan—type 2 diabetes mellitus	0.00062	0.00123	CcSEcCtD
Phenazopyridine—Rash—Losartan—type 2 diabetes mellitus	0.00062	0.00123	CcSEcCtD
Phenazopyridine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000619	0.00123	CcSEcCtD
Phenazopyridine—Headache—Losartan—type 2 diabetes mellitus	0.000616	0.00122	CcSEcCtD
Phenazopyridine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000596	0.00118	CcSEcCtD
Phenazopyridine—Nausea—Losartan—type 2 diabetes mellitus	0.000584	0.00116	CcSEcCtD
Phenazopyridine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000577	0.00114	CcSEcCtD
Phenazopyridine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000536	0.00106	CcSEcCtD
Phenazopyridine—Rash—Ramipril—type 2 diabetes mellitus	0.000531	0.00105	CcSEcCtD
Phenazopyridine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000531	0.00105	CcSEcCtD
Phenazopyridine—Headache—Ramipril—type 2 diabetes mellitus	0.000528	0.00105	CcSEcCtD
Phenazopyridine—Nausea—Ramipril—type 2 diabetes mellitus	0.000501	0.000993	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000221	0.00062	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000219	0.000617	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000218	0.000612	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000217	0.00061	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000212	0.000595	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000212	0.000595	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000211	0.000594	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000208	0.000585	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000204	0.000574	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000204	0.000574	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000204	0.000573	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000201	0.000564	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.0002	0.000562	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.0002	0.000562	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000194	0.000544	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000193	0.000542	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000193	0.000542	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000189	0.000532	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000188	0.000527	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000187	0.000524	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—INS—type 2 diabetes mellitus	0.000186	0.000522	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—SRC—type 2 diabetes mellitus	0.000183	0.000515	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000183	0.000514	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SLC2A2—type 2 diabetes mellitus	0.000183	0.000513	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000179	0.000504	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000179	0.000504	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HNF4A—type 2 diabetes mellitus	0.000179	0.000503	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000177	0.000498	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—GCK—type 2 diabetes mellitus	0.000174	0.00049	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IAPP—type 2 diabetes mellitus	0.000173	0.000487	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000172	0.000485	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000172	0.000485	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000171	0.00048	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TRPC6—type 2 diabetes mellitus	0.000169	0.000476	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—SRC—type 2 diabetes mellitus	0.000169	0.000474	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000169	0.000474	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000166	0.000467	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000166	0.000467	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—INS—type 2 diabetes mellitus	0.000165	0.000465	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000164	0.000462	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000163	0.000459	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000163	0.000458	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000162	0.000456	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PAX6—type 2 diabetes mellitus	0.000162	0.000455	CbGpPWpGaD
Phenazopyridine—SCN5A—L1CAM interactions—EGFR—type 2 diabetes mellitus	0.000161	0.000452	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.00016	0.000449	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000157	0.000441	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000157	0.000441	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SREBF1—type 2 diabetes mellitus	0.000156	0.00044	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000155	0.000436	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000154	0.000433	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000153	0.00043	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000151	0.000425	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000151	0.000425	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—INS—type 2 diabetes mellitus	0.000151	0.000425	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000151	0.000424	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—SRC—type 2 diabetes mellitus	0.00015	0.000423	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000149	0.000419	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000149	0.000419	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000149	0.000419	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000148	0.000416	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000146	0.000412	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000146	0.000411	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000144	0.000406	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000144	0.000404	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000144	0.000404	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—ADIPOQ—type 2 diabetes mellitus	0.000144	0.000404	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000143	0.000402	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000143	0.000401	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000139	0.00039	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000139	0.00039	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—SRC—type 2 diabetes mellitus	0.000138	0.000386	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000137	0.000385	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000137	0.000384	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SLC2A4—type 2 diabetes mellitus	0.000136	0.000381	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000134	0.000376	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000134	0.000376	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PPARA—type 2 diabetes mellitus	0.000134	0.000376	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000133	0.000375	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000132	0.00037	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000132	0.00037	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000132	0.00037	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000131	0.000367	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000129	0.000363	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000127	0.000357	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—LEP—type 2 diabetes mellitus	0.000127	0.000357	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000125	0.000351	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000125	0.000351	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—INS—type 2 diabetes mellitus	0.000122	0.000344	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000121	0.00034	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000121	0.000339	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—EGFR—type 2 diabetes mellitus	0.000121	0.000339	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—SRC—type 2 diabetes mellitus	0.00012	0.000338	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000119	0.000335	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000118	0.000332	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000117	0.000329	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—INS—type 2 diabetes mellitus	0.000117	0.000329	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PPARGC1A—type 2 diabetes mellitus	0.000117	0.000329	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000116	0.000327	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000115	0.000324	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000115	0.000324	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000115	0.000322	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000115	0.000322	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—type 2 diabetes mellitus	0.000114	0.000319	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000113	0.000318	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—INS—type 2 diabetes mellitus	0.000112	0.000316	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—INS—type 2 diabetes mellitus	0.000112	0.000316	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—SRC—type 2 diabetes mellitus	0.000111	0.000313	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000111	0.000312	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000111	0.000312	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000111	0.000311	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—PPARG—type 2 diabetes mellitus	0.000111	0.000311	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000109	0.000305	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000109	0.000305	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—INS—type 2 diabetes mellitus	0.000108	0.000305	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—INS—type 2 diabetes mellitus	0.000108	0.000305	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000108	0.000304	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TGFB1—type 2 diabetes mellitus	0.000108	0.000302	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—SRC—type 2 diabetes mellitus	0.000107	0.000302	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000107	0.0003	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—MMP9—type 2 diabetes mellitus	0.000107	0.0003	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—MMP9—type 2 diabetes mellitus	0.000106	0.000299	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—LPL—type 2 diabetes mellitus	0.000106	0.000299	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—SRC—type 2 diabetes mellitus	0.000106	0.000299	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—EGFR—type 2 diabetes mellitus	0.000106	0.000297	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NFKB1—type 2 diabetes mellitus	0.000105	0.000296	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000105	0.000294	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT2—type 2 diabetes mellitus	0.000105	0.000294	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—VEGFA—type 2 diabetes mellitus	0.000104	0.000294	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000104	0.000292	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—VEGFA—type 2 diabetes mellitus	0.000104	0.000291	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—SRC—type 2 diabetes mellitus	0.000102	0.000287	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SRC—type 2 diabetes mellitus	0.000102	0.000287	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—type 2 diabetes mellitus	0.000101	0.000285	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CD36—type 2 diabetes mellitus	0.000101	0.000284	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—RELA—type 2 diabetes mellitus	0.000101	0.000284	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—TNF—type 2 diabetes mellitus	0.0001	0.000282	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—VEGFA—type 2 diabetes mellitus	9.95e-05	0.00028	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—VEGFA—type 2 diabetes mellitus	9.95e-05	0.00028	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—SRC—type 2 diabetes mellitus	9.85e-05	0.000277	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—SRC—type 2 diabetes mellitus	9.85e-05	0.000277	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SRC—type 2 diabetes mellitus	9.81e-05	0.000276	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—EGFR—type 2 diabetes mellitus	9.75e-05	0.000274	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—RELA—type 2 diabetes mellitus	9.66e-05	0.000271	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—VEGFA—type 2 diabetes mellitus	9.6e-05	0.00027	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—VEGFA—type 2 diabetes mellitus	9.6e-05	0.00027	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TGFB1—type 2 diabetes mellitus	9.59e-05	0.00027	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—VEGFA—type 2 diabetes mellitus	9.56e-05	0.000269	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—EGFR—type 2 diabetes mellitus	9.4e-05	0.000264	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PPARA—type 2 diabetes mellitus	9.4e-05	0.000264	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—EGFR—type 2 diabetes mellitus	9.32e-05	0.000262	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—RELA—type 2 diabetes mellitus	9.28e-05	0.000261	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RELA—type 2 diabetes mellitus	9.28e-05	0.000261	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6—type 2 diabetes mellitus	9.26e-05	0.00026	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—EGFR—type 2 diabetes mellitus	8.96e-05	0.000252	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—EGFR—type 2 diabetes mellitus	8.96e-05	0.000252	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—TNF—type 2 diabetes mellitus	8.96e-05	0.000252	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RELA—type 2 diabetes mellitus	8.95e-05	0.000251	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—RELA—type 2 diabetes mellitus	8.95e-05	0.000251	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—LEP—type 2 diabetes mellitus	8.92e-05	0.000251	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TGFB1—type 2 diabetes mellitus	8.77e-05	0.000247	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—EGFR—type 2 diabetes mellitus	8.64e-05	0.000243	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—EGFR—type 2 diabetes mellitus	8.64e-05	0.000243	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—MMP9—type 2 diabetes mellitus	8.61e-05	0.000242	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—EGFR—type 2 diabetes mellitus	8.6e-05	0.000242	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NFKB1—type 2 diabetes mellitus	8.52e-05	0.000239	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	8.37e-05	0.000235	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—MMP9—type 2 diabetes mellitus	8.23e-05	0.000231	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—TNF—type 2 diabetes mellitus	8.19e-05	0.00023	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—NFKB1—type 2 diabetes mellitus	8.15e-05	0.000229	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6—type 2 diabetes mellitus	8.11e-05	0.000228	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—SRC—type 2 diabetes mellitus	7.94e-05	0.000223	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—MMP9—type 2 diabetes mellitus	7.91e-05	0.000222	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—MMP9—type 2 diabetes mellitus	7.91e-05	0.000222	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NFKB1—type 2 diabetes mellitus	7.83e-05	0.00022	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NFKB1—type 2 diabetes mellitus	7.83e-05	0.00022	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—PPARG—type 2 diabetes mellitus	7.77e-05	0.000218	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—VEGFA—type 2 diabetes mellitus	7.73e-05	0.000217	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—MMP9—type 2 diabetes mellitus	7.63e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—MMP9—type 2 diabetes mellitus	7.63e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—INS—type 2 diabetes mellitus	7.62e-05	0.000214	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SRC—type 2 diabetes mellitus	7.59e-05	0.000213	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NFKB1—type 2 diabetes mellitus	7.55e-05	0.000212	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NFKB1—type 2 diabetes mellitus	7.55e-05	0.000212	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—MMP9—type 2 diabetes mellitus	7.51e-05	0.000211	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—type 2 diabetes mellitus	7.49e-05	0.000211	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—type 2 diabetes mellitus	7.48e-05	0.00021	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—VEGFA—type 2 diabetes mellitus	7.39e-05	0.000208	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT2—type 2 diabetes mellitus	7.37e-05	0.000207	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SRC—type 2 diabetes mellitus	7.29e-05	0.000205	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—SRC—type 2 diabetes mellitus	7.29e-05	0.000205	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—type 2 diabetes mellitus	7.23e-05	0.000203	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—type 2 diabetes mellitus	7.17e-05	0.000201	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—VEGFA—type 2 diabetes mellitus	7.1e-05	0.0002	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—VEGFA—type 2 diabetes mellitus	7.1e-05	0.0002	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TGFB1—type 2 diabetes mellitus	7.09e-05	0.000199	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—SRC—type 2 diabetes mellitus	7.03e-05	0.000198	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SRC—type 2 diabetes mellitus	7.03e-05	0.000198	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—EGFR—type 2 diabetes mellitus	6.96e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—SRC—type 2 diabetes mellitus	6.93e-05	0.000195	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6—type 2 diabetes mellitus	6.88e-05	0.000193	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—type 2 diabetes mellitus	6.88e-05	0.000193	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—VEGFA—type 2 diabetes mellitus	6.85e-05	0.000192	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—VEGFA—type 2 diabetes mellitus	6.85e-05	0.000192	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.79e-05	0.000191	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—VEGFA—type 2 diabetes mellitus	6.75e-05	0.00019	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.67e-05	0.000187	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—EGFR—type 2 diabetes mellitus	6.65e-05	0.000187	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—type 2 diabetes mellitus	6.64e-05	0.000187	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—type 2 diabetes mellitus	6.64e-05	0.000187	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—TNF—type 2 diabetes mellitus	6.62e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—type 2 diabetes mellitus	6.61e-05	0.000186	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.52e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.52e-05	0.000183	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—EGFR—type 2 diabetes mellitus	6.39e-05	0.00018	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—EGFR—type 2 diabetes mellitus	6.39e-05	0.00018	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—TNF—type 2 diabetes mellitus	6.34e-05	0.000178	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—RELA—type 2 diabetes mellitus	6.29e-05	0.000177	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.29e-05	0.000177	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TGFB1—type 2 diabetes mellitus	6.29e-05	0.000177	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—EGFR—type 2 diabetes mellitus	6.16e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—EGFR—type 2 diabetes mellitus	6.16e-05	0.000173	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—type 2 diabetes mellitus	6.1e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—TNF—type 2 diabetes mellitus	6.09e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—TNF—type 2 diabetes mellitus	6.09e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—EGFR—type 2 diabetes mellitus	6.07e-05	0.000171	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—TNF—type 2 diabetes mellitus	5.87e-05	0.000165	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—TNF—type 2 diabetes mellitus	5.87e-05	0.000165	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—MMP9—type 2 diabetes mellitus	5.36e-05	0.000151	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6—type 2 diabetes mellitus	5.35e-05	0.00015	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NFKB1—type 2 diabetes mellitus	5.31e-05	0.000149	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—type 2 diabetes mellitus	5.11e-05	0.000144	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—SRC—type 2 diabetes mellitus	4.94e-05	0.000139	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.93e-05	0.000139	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—type 2 diabetes mellitus	4.91e-05	0.000138	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6—type 2 diabetes mellitus	4.91e-05	0.000138	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—VEGFA—type 2 diabetes mellitus	4.82e-05	0.000135	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—type 2 diabetes mellitus	4.74e-05	0.000133	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—type 2 diabetes mellitus	4.74e-05	0.000133	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.72e-05	0.000133	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—type 2 diabetes mellitus	4.67e-05	0.000131	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.53e-05	0.000127	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.53e-05	0.000127	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TGFB1—type 2 diabetes mellitus	4.42e-05	0.000124	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.37e-05	0.000123	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—type 2 diabetes mellitus	4.37e-05	0.000123	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—EGFR—type 2 diabetes mellitus	4.33e-05	0.000122	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—TNF—type 2 diabetes mellitus	4.13e-05	0.000116	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—type 2 diabetes mellitus	3.33e-05	9.36e-05	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—type 2 diabetes mellitus	3.07e-05	8.63e-05	CbGpPWpGaD
